Literature DB >> 24294518

RE: Takatori K, Terashima K, Yoshida R, Horai A, Satake S, Ose T, Kitajima N, Kinoshita Y, Demizu Y, Fuwa N. Upper gastrointestinal complications associated with gemcitabine-concurrent proton radiotherapy for inoperable pancreatic cancer. J Gastroenterol. 2013; (E-pub only).

R Charles Nichols1, Bradford S Hoppe.   

Abstract

Entities:  

Year:  2013        PMID： 24294518      PMCID： PMC3819775          DOI： 10.3978/j.issn.2078-6891.2013.048

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN： 2078-6891


× No keyword cloud information.
  3 in total

1.  Protons offer reduced normal-tissue exposure for patients receiving postoperative radiotherapy for resected pancreatic head cancer.

Authors:  Romaine C Nichols; Soon N Huh; Karl L Prado; Byong Y Yi; Navesh K Sharma; Meng W Ho; Bradford S Hoppe; Nancy P Mendenhall; Zuofeng Li; William F Regine
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-01-13       Impact factor: 7.038

2.  Proton therapy with concomitant capecitabine for pancreatic and ampullary cancers is associated with a low incidence of gastrointestinal toxicity.

Authors:  R Charles Nichols; Thomas J George; Robert A Zaiden; Ziad T Awad; Horacio J Asbun; Soon Huh; Meng Wei Ho; Nancy P Mendenhall; Christopher G Morris; Bradford S Hoppe
Journal:  Acta Oncol       Date:  2013-04       Impact factor: 4.089

3.  Upper gastrointestinal complications associated with gemcitabine-concurrent proton radiotherapy for inoperable pancreatic cancer.

Authors:  Kento Takatori; Kazuki Terashima; Rihito Yoshida; Aya Horai; Shinya Satake; Takayuki Ose; Naoto Kitajima; Yoshikazu Kinoshita; Yusuke Demizu; Nobukazu Fuwa
Journal:  J Gastroenterol       Date:  2013-07-12       Impact factor: 7.527
  3 in total
  3 in total

Review 1.  Proton Therapy in the Management of Pancreatic Cancer.

Authors:  Jana M Kobeissi; Charles B Simone; Haibo Lin; Lara Hilal; Carla Hajj
Journal:  Cancers (Basel)       Date:  2022-06-04       Impact factor: 6.575

Review 2.  Proton therapy for pancreatic cancer.

Authors:  Romaine C Nichols; Soon Huh; Zuofeng Li; Michael Rutenberg
Journal:  World J Gastrointest Oncol       Date:  2015-09-15

Review 3.  Effective radiotherapeutic treatment intensification in patients with pancreatic cancer: higher doses alone, higher RBE or both?

Authors:  Constantin Dreher; Daniel Habermehl; Oliver Jäkel; Stephanie E Combs
Journal:  Radiat Oncol       Date:  2017-12-27       Impact factor: 3.481
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.